PATENT CLAIM ANALYSIS

Application Number: 16394308
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "253000"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 14 , W, A and n are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring a pro-apoptotic agent.

Claim (Index 33):
The method according to  claim 32 , wherein the condition is selected from cancers of the bladder, brain, breast and uterus, chronic lymphoid leukaemias, cancer of the colon, oesophagus and liver, lymphoblastic leukaemias, acute myeloid leukaemias, lymphomas, melanomas, malignant haemopathies, myelomas, ovarian cancer, non-small-cell lung cancer, prostate cancer, pancreatic cancer and small-cell lung cancer.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 100.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15738186', '15737479', '15737783', '15738601', '15492306']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8017075047544132
- 35 USC 102 Novelty (BERT): 0.5700322940737163
- Combined Prediction Score: 0.7785399836863436
- Mean Citation Score: 423.82738200000006
- Max Citation Score: 447.99300000000005
- Similarity Product: 375.1280115190745

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test